$FIGS

FIGS (FIGS) Q2 2026 Earnings Call Transcript

FIGS, Inc. (FIGS) reported Q2 2026 net revenues of $196.6 million, up 28.8%, driven by higher order volume and record average order values. Scrubwear revenue rose 26.5% to $161.2 million. Gross margin was 75.2% and net income $28.4 million. The company raised FY2026 net revenue guidance to about 20% growth and EBITDA margin to 14.8% to 15.0%.

Original reporting
Published Aug 14, 2026, 2:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 3:03 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
FIGS (FIGS) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$FIGSBullishHigh
01

Why it matters

The key tradable items are the raised FY2026 net revenue growth outlook (~20% vs prior 14% to 16%), lifted adjusted EBITDA margin range (14.8% to 15.0% vs prior 13% to 13.2%), and the operational drivers behind gross margin and cash improvement, offset by a customs withhold release order risk.

02

Market read

Traders can update models immediately using the raised FY2026 growth and margin ranges, while monitoring the customs withhold release order that could disrupt U.S. imports.

03

What to watch

Q4 is guided as the lowest gross margin quarter of the year, and import restrictions tied to a Jordan partner may force costly mitigation (airfreight, partner switching) that could pressure margins later.

Relevance 9/10Novelty 8/10Timing: earnings call transcript released Aug. 6, 2026, with updated FY2026 and Q3/Q4 growth guidance

Background

FIGS held its Q2 fiscal 2026 earnings call, reporting results and updating full-year and quarterly growth and margin guidance.

Company-level read

Ticker impact

$FIGSBullishMedium confidence
Context

FIGS reported Q2 2026 net revenues of $196.6M, raised FY2026 net revenue growth guidance to ~20%, and lifted adjusted EBITDA margin to 14.8% to 15.0%.

Expected impact

Bias toward upside revisions and higher multiple if investors believe tariff refunds are repeatable and customer growth sustains.

Evidence & confidence

The article provides multiple concrete, decision-relevant datapoints: raised full-year growth and margin ranges, improved gross margin with IEEPA tariff refunds, and active customer growth. It also flags a U.S. Customs withhold release order risk that could disrupt imports, partially offsetting the positive read-through.

Market effects

Improves sentiment for direct-to-consumer healthcare apparel names by highlighting operating leverage and margin recovery drivers (tariff refunds, shipping rates, marketing efficiency).

International growth acceleration (67% international net revenue growth) supports the narrative that non-U.S. demand is becoming a larger earnings driver.

Tariff and customs enforcement dynamics (IEEPA/WRO) underscore supply-chain and policy risk that can affect apparel importers broadly.

Counterpoint

Tariff-refund-driven gross margin expansion may not be durable, and the U.S. withhold release order could create recurring inventory and fulfillment volatility.

Key entities

  • FIGS, Inc.

    Reported Q2 2026 results, raised FY2026 guidance, and discussed customs import restrictions and tariff-refund impacts.

  • Bupa Dental Care

    Onboarded via FIGS TEAMS platform, outfitting nearly 400 UK dental centers.

  • V Coterie

    FIGS confirmed acquisition to expand personalized healthcare jewelry/accessories offerings.

Related articles

$FIGSMedAI 8/10

FIGS Stock Soars After Earnings Beat And Upgraded Outlook

FIGS Inc. (NYSE: FIGS) shares rose about 28.7% in a week after a Q2 earnings beat and an upgraded FY26 outlook, according to the article. Q2 results included EPS $0.15 vs $0.07 and revenue up 29% to $196.6M, with gross margin 66.6% and adjusted EBITDA margin 18.6%. FY26 guidance was raised to about 20% revenue growth and 14.8% to 15% EBITDA margin.

$FIGSHighAI 9/10

FIGS Q2 Earnings Call Highlights

FIGS (NYSE:FIGS) reported Q2 results and an earnings call update. International revenue rose 67% to $37.9M and U.S. revenue grew 22% to $158.7M. Gross margin increased to 75.2% with a $15.4M tariff refund benefit. Net income was $28.4M, or $0.15/share. FIGS raised FY2026 revenue growth to ~20% and operating margin to ~10.8%, and repurchased about $24M of shares.

$FIGSHighAI 9/10

FIGS Stock Jumped 27% on Its Q2 Beat. The Raised Guide Did the Real Work.

FIGS (FIGS) shares rose about 27% on Aug. 7 after Q2 results beat estimates and management raised full-year guidance. Q2 revenue was $196.6M (+29% YoY) and EPS was $0.15 vs $0.07 consensus. Gross margin hit 75.2% but included a one-time tariff refund; core margin improved. Full-year growth guidance lifted to ~20% from 14% to 16%, plus a $100M buyback authorization.

$FIGSMedAI 8/10

FIGS, Inc. Lifts Outlook Amid Robust Growth

FIGS, Inc. (FIGS) reported Q2 results and lifted full-year revenue growth guidance to about 20%. Net revenues rose 29% to $196.6M, with gross margin up 820 bps to 75.2% and operating margin to 17.9%. Management cited $20.5M tariff refunds and raised 2026 operating margin and adjusted EBITDA outlooks, while noting Q3 margin pressure from a Jordan import hold and airfreight.

$FIGSHighAI 8/10

Why Figs Stock Popped Today

Figs (NYSE: FIGS) shares rose after the medical apparel company reported Q2 results above expectations. Net revenue increased 28.8% to $196.6 million, with active customers up 13.2% to 3.1 million. Gross margin rose to 75.2% and net income rose to $28.4 million, or $0.15 per share. Figs raised its 2026 revenue growth outlook to about 20% and increased its buyback by $100 million.

$FIGSMedAI 8/10

Why Is Figs (FIGS) Stock Soaring Today

Figs (NYSE: FIGS) shares rose about 28.5% after the company reported Q2 2026 results that beat Wall Street on revenue and adjusted EPS. Active customers increased 13% to 3.1 million, average order value rose to $127, adjusted EPS was $0.11 vs $0.07 consensus, and operating margin widened to 17.9% from 6.5%. The board raised its buyback authorization and FCF turned positive.